Conduit Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-2.3	-0.54	-4.89	-3.66
Share-Based Compensation	0.63	0.2	0	0
Other Operating Activities	-6.45	-7.39	2.62	1.51
Operating Cash Flow	-8.11	-7.73	-2.27	-2.15
Acquisitions	-0.11	-0.36	-0.33	0
Change in Investments	1.08	1.08	0.15	0
Investing Cash Flow	0.97	0.73	-0.18	0
Share Issuance / Repurchase	8.64	8.64	0	0
Debt Issued / Paid	0.07	2.29	1.11	0.69
Other Financing Activities	-	-	1.34	1.21
Financing Cash Flow	8.71	10.93	2.45	1.9
Exchange Rate Effect	0.27	0.3	0	0
Net Cash Flow	1.84	4.23	0	-0.25
Free Cash Flow	-8.11	-7.73	-2.27	-2.15
Free Cash Flow Per Share	-0.11	-0.12	-0.06	-0.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).